EIF — MedNation AG Income Statement
0.000.00%
Last trade - 00:00
- €3.68m
- €16.80m
- €37.55m
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | Interim Report | Interim Report |
Standards: | IFRS | IFRS | IFRS | — | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 49.3 | 48.5 | 35.5 | 35.8 | 37.5 |
Cost of Revenue | |||||
Gross Profit | 47.3 | 46.7 | 34.3 | 34.3 | 35.9 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 49.1 | 45.6 | 34.1 | 37 | 36.2 |
Operating Profit | 0.226 | 2.81 | 1.37 | -1.16 | 1.33 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -0.597 | -0.075 | -1.19 | -4.1 | -1.72 |
Provision for Income Taxes | |||||
Net Income After Taxes | -1.04 | -0.682 | -1.31 | -4.22 | -1.85 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -1.11 | -0.773 | -1.42 | -4.4 | -1.89 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -1.11 | -0.773 | -1.42 | -4.4 | -1.89 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.368 | -0.357 | -0.47 | -1.46 | -0.626 |
Dividends per Share |